RAPPORTEUR (EURACTIV) - Brussels wants the world's best biotech medicines to be born in Europe, and it is willing to pay in time. Companies that beat what is already on the shelf and do it on European soil would get one more year before a rival can copy them. Read more

RAPPORTEUR (EURACTIV) - Patients with rare neurological diseases wait around five years for a diagnosis, by which time their condition may have deteriorated, says Marullo di Condojanni. Unmet need in the field exceeds 90 per cent, but the problem, he argues, lies less in the science than in the system around it. Read more

RAPPORTEUR (EURACTIV) - The EU must open an investigation against Washington for "unlawful coercion in national matters", Belgian Deputy Prime Minister and Health Minister Frank Vandenbroucke said on Tuesday, 6 October. Read more

EURACTIV - A decade after the first biosimilar reached European patients with rheumatoid arthritis, the evidence is in: patients do as well on the copies as on the original biologics, and a million patient-years of use confirm they are safe. Read more

EU PERSPECTIVES - A weight-loss jab bought through a social media advert can contain the wrong drug, the wrong dose, or no active ingredient at all. Fake medicines now reach Europeans through the same feeds as holiday photos. Every advert earns the platform money, and the tools to stop it already sit in EU law. Read more

EU PERSPECTIVES - New medicines mean little if patients cannot get them. EU Health Commissioner Olivér Várhelyi promised in Dublin that Europe will beat the US and China in biotech. In Gastein, drugmakers warned that patients in Europe still wait far too long. Read more

EU PERSPECTIVES - The world still has no clear picture of how much it spends preparing for the next pandemic. The EU wants to change that, pushing for a global spending tracker as countries struggle to agree on a new UN declaration on pandemic preparedness. Read more

EU PERSPECTIVES - Cardiovascular disease kills around 1.7 million people in the EU every year. The European Commission now wants regular checks to catch the risks earlier. And Oliver Várhelyi is leading by example. Read more

EU PERSPECTIVES - Drug makers say European patients miss out on four in ten new medicines. The OECD says about half of new medicines work no better than what patients already get. Who is right will shape what Europe pays for and which cures reach its patients. Read more

EU PERSPECTIVES - Lawmakers want to plug the health staff gap by 2034. They also demand binding limits on unsafe staffing — and the EU budget to pay for it. Read more